See all treatments in the PatientsLikeMe system shared by patients just like you.
Brand Names:
Mirapex, Sifrol, Mirapexin, Novo-Pramipexole
Generic Name: Pramipexole
What is Pramipexole? Pramipexole is an anti-Parkinson's agent that is used to treat symptoms of Parkinson's Disease, such as stiffness, tremors, muscle spasms, and poor muscle control and for moderate to severe primary restless legs syndrome. Off label it is used for the treatment of depression.
See more information, including instructions, precautions, side effects, and interactions.
| Reason | # Patients | Percentage of patients |
|---|---|---|
| Treat Parkinson's | 430 | 66% |
| Stiffness/Spasticity | 19 | 2% |
| Other | 17 | 2% |
| tremor | 16 | 2% |
| Slowness | 7 | 1% |
| Restless Legs Syndrome (RLS) | 6 | <1% |
| Mobility | 5 | <1% |
| disease-related symptoms | 4 | <1% |
| General health | 3 | <1% |
| Don't know | 3 | <1% |
Other treatments patients are taking for Treat Parkinson's include Carbidopa-Levodopa, Ropinirole, and Rasagiline.
| 0.125mg as needed | 0 1mg as needed | 0.25mg as needed | 0.375mg as needed | 0.5 mg all the time (24/7) | 0.5mg as needed | 1.5 mg all the time (24/7) | 1.5mg as needed | 3 0.125mg as needed | 3 1mg as needed | daily | 0.025 mg daily | 0.125 mg daily | 0.15 mg daily | 0.18 mg daily | 0.25 mg daily | 0.3 mg daily | 0.3125 mg daily | 0.375 mg daily | 0.5 daily | 0.5 mg daily | 0.72 mg daily | 0.75 mg daily | 0.875 mg daily | 1 daily | 1 mg daily | 1.08 mg daily | 1.25 mg daily | 1.5 daily | 1.5 mg daily | 1.75 mg daily | 2 mg daily | 2.1 mg daily | 2.25 mg daily | 2.46 mcg daily | 2.5 mg daily | 2.8 mg daily | 3 daily | 3 mg daily | 3.25 mg daily | 3.5 mg daily | 3.75 daily | 3.75 mg daily | 4 mg daily | 4.25 mg daily | 4.5 mg daily | 5 mg daily | 6 mg daily | 6.5 mg daily | 7.5 mg daily | 9 mg daily | 20 mg daily | 25 mg daily | 50 daily | 75 mg daily | 100 mg daily | 200 daily | 200 other daily | 225 mg daily | 300 mg daily | 500 mg daily | 750 mg daily | 3000 mg daily | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
9
|
1
|
11
|
1
|
1
|
12
|
1
|
1
|
22
|
1
|
18
|
1
|
25
|
2
|
1
|
29
|
1
|
2
|
1
|
77
|
2
|
18
|
2
|
21
|
1
|
8
|
1
|
1
|
89
|
1
|
2
|
1
|
2
|
21
|
1
|
73
|
6
|
18
|
1
|
1
|
2
|
1
|
2
|
1
|
2
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
||
How long current patients have been taking Pramipexole or how long patients were taking Pramipexole before stopping.
Results from 130 patient evaluations. See the overall results and all individual evaluations.
| Major | 21% | 20 |
|---|---|---|
| Moderate | 52% | 50 |
| Slight | 13% | 12 |
| None | 5% | 5 |
| Can't tell | 9% | 9 |
Treat Parkinson's
| Severe | 14% | 18 |
|---|---|---|
| Moderate | 33% | 43 |
| Mild | 27% | 35 |
| None | 26% | 34 |
Top reported side-effects include: Drowsiness, Weight gain, Insomnia
Summary results are based on 130 individual responses. For more information, see overall results for Adherence, Burden and Cost.
Report created on November 07, 2009.